Salvia BioElectronics has raised 26 million euros ($30 million) in new financing to fund development of a neurostimulation therapy for chronic migraine. Neurostimulation has been proven as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback